NCT05489237 2025-11-17First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsIDRx Inc. - A GSK CompanyPhase 1 Recruiting278 enrolled
NCT05160168 2024-06-05A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Theseus PharmaceuticalsPhase 1/2 Terminated32 enrolled 20 charts
NCT00867113 2018-03-14Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)NovartisPhase 2 Completed91 enrolled 11 charts